Fundz

Xilio Therapeutics Appoints Caroline (Holda) Hensley as Chief Legal Officer

PUBLIC · XLODec 16, 2024

Position

Chief Legal Officer

Company

Xilio Therapeutics

Caroline (Holda) Hensley
chensley@xiliotx.com
WalthamBiotechnologyHealth CareTherapeutics

Description

Xilio Therapeutics, Inc. has announced the appointment of Caroline (Holda) Hensley as chief legal officer

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Xilio Therapeutics, and when

A new leader at Xilio Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Xilio Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xilio Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xilio Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xilio Therapeutics

Location

Waltham, Massachusetts, United States

About

Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xilio Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Christopher
Likely contact at this company
••••••••@••••••••

See Christopher's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Xilio Therapeutics's next move

Learn about Strategic plan

Xilio Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.